Inactive Instrument
RAMM Pharma Corp. Stock OTC Markets
Stocks
RAMMF
CA75150G1046
Pharmaceuticals
OTC Markets Traded| Market Cap | 597K 425K 372K 344K 315K 40.97M 607K 4.1M 1.61M 20.01M 1.6M 1.56M 69.08M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | -127K -90.14K -78.79K -72.86K -66.86K -8.69M -129K -869K -341K -4.24M -338K -331K -14.64M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -76.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -76.29% | -92.33% | - | - | 425K | ||
| +1.39% | -3.78% | +48.26% | +161.87% | 1,031B | ||
| +0.74% | -4.26% | +50.53% | +55.94% | 595B | ||
| +3.13% | +0.69% | +32.04% | +86.63% | 431B | ||
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | ||
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | ||
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | ||
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | ||
| +2.87% | +1.23% | +23.11% | +61.57% | 193B | ||
| +2.23% | -0.36% | +22.30% | +73.40% | 164B | ||
| Average | -6.30% | -3.79% | +25.97% | +54.96% | 389.37B | |
| Weighted average by Cap. | +1.41% | -4.31% | +34.25% | +79.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.09M 2.7M 2.5M 2.29M 298M 4.42M 29.82M 11.71M 146M 11.61M 11.36M 502M | 3.36M 2.39M 2.09M 1.94M 1.78M 231M 3.42M 23.08M 9.07M 113M 8.99M 8.79M 389M |
| Net income | -16.5M -11.75M -10.27M -9.5M -8.72M -1.13B -16.79M -113M -44.52M -553M -44.14M -43.17M -1.91B | -8.91M -6.35M -5.55M -5.13M -4.71M -612M -9.06M -61.18M -24.04M -299M -23.83M -23.31M -1.03B |
| Net Debt | -626K -446K -390K -360K -331K -42.95M -637K -4.3M -1.69M -20.97M -1.67M -1.64M -72.41M | -723K -515K -450K -417K -382K -49.66M -736K -4.97M -1.95M -24.25M -1.94M -1.89M -83.72M |
Employees
-
Sector
Pharmaceuticals
















